The Global Biopharmaceutical Market is estimated to be USD 330.7 Bn in 2021 and is expected to reach USD 478.08 Bn by 2026, growing at a CAGR of 7.65%.
Market Dynamics
The factors such as constant innovations in biopharmaceutics, the growing elderly population, increasing unhealthy lifestyle, rising chronic diseases, and focus on research and related investments have prompted the demand of the global biopharmaceutical market. According to the Globocan 2020 report, 19,292,789 new cancer cases were diagnosed, with 9,958,133 deaths due to cancers worldwide. Growing healthcare expenditures, improved healthcare infrastructures, and government initiatives in the biopharmaceutical sector are anticipated to increase market growth further. However, some factors, such as stringent pharmaceutical regulations, can create hindrances in innovating new novel drugs that may affect the market growth.
Rising adoption in emerging economies is expected to generate untapped opportunities for market participants.
Market Segmentation
The Global Biopharmaceutical Market is segmented further based on Product Type, Therapeutic Application, and Geography.
By Product Type, the market is classified into monoclonal antibodies, recombinant growth factors, purified proteins, recombinant proteins, recombinant hormones, vaccines, synthetic immunomodulators, recombinant enzymes, cell and gene therapies, and others. Amongst all, the monoclonal antibodies segment is estimated to hold the highest market share during the forecast period.
By Therapeutic Application, the market is classified as oncology, cardiology, neurology, autoimmune disorders, hormonal disorders, and others. Amongst all, the oncology segment is estimated to hold the highest market share during the forecast period.
By Geography, North America is projected to lead the market.
Recent Developments
1. Pfizer acquired Amplyx pharmaceuticals to advance the anti-infectives pipeline - 30th April 2021.
2. Biogen and Bio-Thera Solutions announce commercialization and license agreement for bat1806 - 13th April 2021.
Company Profiles
Some of the companies covered in this report are Abbott Laboratories, Amgen Inc, Beijing SL Pharmaceutical Co Ltd, Biocon Ltd, Biological E. Limited, etc.
Competitive Quadrant
The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Why buy this report?
Report Highlights:
Market Dynamics
The factors such as constant innovations in biopharmaceutics, the growing elderly population, increasing unhealthy lifestyle, rising chronic diseases, and focus on research and related investments have prompted the demand of the global biopharmaceutical market. According to the Globocan 2020 report, 19,292,789 new cancer cases were diagnosed, with 9,958,133 deaths due to cancers worldwide. Growing healthcare expenditures, improved healthcare infrastructures, and government initiatives in the biopharmaceutical sector are anticipated to increase market growth further. However, some factors, such as stringent pharmaceutical regulations, can create hindrances in innovating new novel drugs that may affect the market growth.
Rising adoption in emerging economies is expected to generate untapped opportunities for market participants.
Market Segmentation
The Global Biopharmaceutical Market is segmented further based on Product Type, Therapeutic Application, and Geography.
By Product Type, the market is classified into monoclonal antibodies, recombinant growth factors, purified proteins, recombinant proteins, recombinant hormones, vaccines, synthetic immunomodulators, recombinant enzymes, cell and gene therapies, and others. Amongst all, the monoclonal antibodies segment is estimated to hold the highest market share during the forecast period.
By Therapeutic Application, the market is classified as oncology, cardiology, neurology, autoimmune disorders, hormonal disorders, and others. Amongst all, the oncology segment is estimated to hold the highest market share during the forecast period.
By Geography, North America is projected to lead the market.
Recent Developments
1. Pfizer acquired Amplyx pharmaceuticals to advance the anti-infectives pipeline - 30th April 2021.
2. Biogen and Bio-Thera Solutions announce commercialization and license agreement for bat1806 - 13th April 2021.
Company Profiles
Some of the companies covered in this report are Abbott Laboratories, Amgen Inc, Beijing SL Pharmaceutical Co Ltd, Biocon Ltd, Biological E. Limited, etc.
Competitive Quadrant
The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Why buy this report?
- The report offers a comprehensive evaluation of the Global Biopharmaceutical Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
- The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
- The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
- The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
- The report also contains the competitive analysis using Positioning Quadrants, the analyst’s positioning tool.
Report Highlights:
- A complete analysis of the market, including parent industry
- Important market dynamics and trends
- Market segmentation
- Historical, current, and projected size of the market based on value and volume
- Market shares and strategies of key players
- Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Biopharmaceutical Market
What is the estimated value of the Global Biopharmaceutical Market?
What is the growth rate of the Global Biopharmaceutical Market?
What is the forecasted size of the Global Biopharmaceutical Market?
Who are the key companies in the Global Biopharmaceutical Market?
Report Attribute | Details |
---|---|
No. of Pages | 230 |
Published | May 2021 |
Forecast Period | 2021 - 2026 |
Estimated Market Value ( USD
| USD 330700 Million |
Forecasted Market Value ( USD
| USD 478080 Million |
Compound Annual Growth Rate | 7.6% |
Regions Covered | Global |
No. of Companies Mentioned | 26 |
Table of Contents
1 Report Description
2 Research Methodology
3 Executive Summary
4 Market Influencers
5 Market Analysis
6 Global Biopharmaceutical Market, By Product Type
7 Global Biopharmaceutical Market, By Therapeutic Application
8 Global Biopharmaceutical Market, By Geography
9 Competitive Landscape
10 Company Profiles
11 Appendix
Companies Mentioned
- Abbott Laboratories
- Amgen Inc
- Beijing SL Pharmaceutical Co Ltd
- Biocon Ltd
- Biological E Limited
- Cadila Healthcare Limited (Zydus Cadila)
- Celltrion, Inc
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd.
- Glenmark Pharmaceuticals Limited
- GVK Biosciences Pvt Ltd
- Hualan Biological Engineering Inc
- Johnson & Johnson
- Merck & Co., Inc
- Novo Nordisk A/S
- Pfizer Inc.
- Reliance Life Sciences Pvt Ltd
- RPG Life Sciences Limited
- Samsung Biologics Co Ltd
- Sanofi S.A.
- Shanghai Institute of Biological Products
- Shantha Biotechnics Ltd
- Sun Pharmaceutical Industries Ltd
- Suven Life Sciences Ltd
- Takeda Pharmaceutical Company Limited
- Torrent Pharmaceuticals Limited